These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1207 related items for PubMed ID: 17701884

  • 1. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S, Dittrich R, Binder H, Kajaia N, Hoffmann I, Maltaris T, Beckmann MW, Mueller A.
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [Abstract] [Full Text] [Related]

  • 2. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone.
    Mueller A, Dittrich R, Cupisti S, Beckmann MW, Binder H.
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):182-7. PubMed ID: 16705550
    [Abstract] [Full Text] [Related]

  • 3. Endocrinological markers for assessment of hyperandrogenemia in hirsute women.
    Mueller A, Cupisti S, Binder H, Hoffmann I, Kiesewetter F, Beckmann MW, Dittrich R.
    Horm Res; 2007 Apr; 67(1):35-41. PubMed ID: 17019078
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of different diagnostic methods for assessment of hyperandrogenism in young women with hirsutism.
    Chanukvadze D, Kristesashvili J.
    Georgian Med News; 2011 Nov; 11(200):25-9. PubMed ID: 22201076
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of biochemical hyperandrogenemia and body mass index in women presenting with amenorrhea.
    Cupisti S, Dittrich R, Binder H, Beckmann MW, Mueller A.
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):298-302. PubMed ID: 17516292
    [Abstract] [Full Text] [Related]

  • 6. [Correlations between clinical signs and hormonal parameters in young women with hirsutism].
    Kristesashvili J, Chanukvadze D.
    Georgian Med News; 2011 Nov; 11(200):30-5. PubMed ID: 22201077
    [Abstract] [Full Text] [Related]

  • 7. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF, Li X, Zhu MW.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [Abstract] [Full Text] [Related]

  • 8. The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome.
    Yasmin E, Balen AH, Barth JH.
    Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):173-7. PubMed ID: 23102586
    [Abstract] [Full Text] [Related]

  • 9. Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria.
    Mueller A, Dittrich R, Binder H, Hoffmann I, Beckmann MW, Cupisti S.
    Eur J Med Res; 2006 Dec 14; 11(12):540-4. PubMed ID: 17182367
    [Abstract] [Full Text] [Related]

  • 10. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D, Rousso D, Koliakos G, Kourtis A, Katsikis I, Farmakiotis D, Votsi E, Diamanti-Kandarakis E.
    Fertil Steril; 2006 Jun 14; 85(6):1778-83. PubMed ID: 16650418
    [Abstract] [Full Text] [Related]

  • 11. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T, Dehghan-Kooshkghazi M.
    Gynecol Endocrinol; 2003 Feb 14; 17(1):51-6. PubMed ID: 12724019
    [Abstract] [Full Text] [Related]

  • 12. Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.
    Nadaraja RND, Sthaneshwar P, Razali N.
    Malays J Pathol; 2018 Apr 14; 40(1):33-39. PubMed ID: 29704382
    [Abstract] [Full Text] [Related]

  • 13. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N.
    Hum Reprod; 2008 Jul 14; 23(7):1602-6. PubMed ID: 18378560
    [Abstract] [Full Text] [Related]

  • 14. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
    Panidis D, Farmakiotis D, Rousso D, Katsikis I, Delkos D, Piouka A, Gerou S, Diamanti-Kandarakis E.
    Eur J Intern Med; 2008 Oct 14; 19(6):406-12. PubMed ID: 18848173
    [Abstract] [Full Text] [Related]

  • 15. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA, Granata A, D'Arrigo F, Arena D, Panacea A, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1990 Oct 14; 21(3):139-41. PubMed ID: 2149912
    [Abstract] [Full Text] [Related]

  • 16. Dyslipidemia with particular regard to apolipoprotein profile in association with polycystic ovary syndrome: a study among Indian women.
    Maitra A, Pingle RR, Menon PS, Naik V, Gokral JS, Meherji PK.
    Int J Fertil Womens Med; 2001 Oct 14; 46(5):271-7. PubMed ID: 11720200
    [Abstract] [Full Text] [Related]

  • 17. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
    Pavičić Baldani D, Škrgatić L, Bukvić Mokos Z, Trgovčić I.
    Acta Dermatovenerol Croat; 2013 Oct 14; 21(2):105-12. PubMed ID: 24001418
    [Abstract] [Full Text] [Related]

  • 18. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul 14; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 19. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS, Rouzi AA.
    Fertil Steril; 2005 Jun 14; 83(6):1708-16. PubMed ID: 15950640
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG, Guo Y, Ma LA, Xing J, Sun RF, Zhu W.
    J Cosmet Dermatol; 2018 Jun 14; 17(3):511-517. PubMed ID: 28940857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.